SEC Info - Cardlytics, Inc. - ‘S-8’ on 1/29/24

SEC Info℠

Home

My Interests

Help

Please Sign In

Cardlytics, Inc. – ‘S-8’ on 1/29/24

On: Monday, 1/29/24, at 7:34am ET · Effective: 1/29/24 · Accession #: 1666071-24-24 · File #: 333-276737

Previous ‘S-8’: ‘S-8’ on 7/18/23 · Latest ‘S-8’: This Filing · 19 References:

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/29/24  Cardlytics, Inc.                  S-8         1/29/24    5:189K

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     73K 
                Employee Benefit Plan                                            
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     11K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML      6K 
 5: EX-23.2     Consent of Expert or Counsel                        HTML     11K 
 2: EX-FILING FEES  Filing Fees                                     HTML     20K

‘S-8’ — Registration Statement – Securities for an Employee Benefit Plan

Document Table of Contents

Page	(sequential)	(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Power of Attorney (included on the signature page of this Form S-8)
1	1st Page – Filing Submission
"	Power of Attorney (included on the signature page of this Form S-8)

This is an HTML Document rendered as filed. [ Alternative Formats ]

C: C:

Document

As filed with the Securities and Exchange Commission on January 29, 2024

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933


			CARDLYTICS, INC.
			(Exact Name of Registrant as Specified in its Charter)


	675 Ponce de Leon Avenue NE, Suite 4100
Delaware	Atlanta, Georgia 30308	26-3039436
(State or other jurisdiction of incorporation or organization)	(Address of principal executive offices) (Zip code)	(I.R.S. Employer Identification No.)

2018 Equity Incentive Plan

2018 Employee Stock Purchase Plan

(Full title of the plan)

Karim Temsamani

Cardlytics, Inc.

675 Ponce de Leon Avenue NE, Suite 4100

Atlanta, Georgia 30308

(Name and address of agent for service)

(888) 798-5802

(Telephone number, including area code, of agent for service)

Copies to:

Mark Ballantyne

Eric Jensen

Cooley LLP

One Freedom Square

Reston Town Center

11951 Freedom Drive

Reston, VA 20190

(703) 456-8000

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐

EXPLANATORY NOTE

Pursuant to General Instruction E of Form S-8, Cardlytics, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register 1,986,417 additional shares of its common stock under the 2018 Equity Incentive Plan (the “2018 Plan”) and 397,283 additional shares of its common stock under the 2018 Employee Stock Purchase Plan (the “2018 ESPP”), pursuant to the provisions of the 2018 Plan and the 2018 ESPP providing for an automatic increase in the number of shares of common stock reserved and available for issuance under the 2018 Plan and the 2018 ESPP, as applicable, on January 1, 2024. In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of the Form S-8 has been omitted from this Registration Statement.

PART II

ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE

The following documents filed by the Registrant with the Commission are incorporated by reference into this Registration Statement:

(a) The contents of the earlier registration statements related to the 2018 Plan and the 2018 ESPP, previously filed with the Commission on February 9, 2018 (File No. 333-222965), May 21, 2019 (File No. 333-231640), March 3, 2020 (File No. 333-236869), March 1, 2021 (File No. 333-253675), March 1, 2022 (File No. 333-263143) and January 23, 2023 (File No. 333-269361) are incorporated herein by reference and made a part of this Registration Statement.

(b) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Commission on March 1, 2023.

(c) The information specifically incorporated by reference into the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022 from the Registrant’s definitive proxy statement on Schedule 14A, as filed with the Commission on April 10, 2023.

(d) The Registrant’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, which were filed with the Commission on May 4, 2023, August 1, 2023 and November 8, 2023, respectively.

(e) The Registrant’s Current Reports on Form 8-K filed with the Commission on January 23, 2023 (with respect to Item 5.02 only), March 14, 2023, March 22, 2023, May 1, 2023, May 24, 2023, July 5, 2023, July 10, 2023, July 18, 2023 (with respect to Item 5.02 only), September 6, 2023 (with respect to Item 5.02 only), September 19, 2023 (with respect to Items 1.01 and 5.02 only), October 30, 2023, December 19, 2023 and January 2, 2024 (with respect to Item 5.02 only).

(f) The description of the Registrant’s Common Stock which is contained in the Registrant’s Registration Statement on Form 8-A filed on February 6, 2018 (File No. 001-38386) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description, including Exhibit 4.3 to the Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the Commission on March 3, 2020.

(g) All other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

ITEM 8. EXHIBITS


Exhibit Number		Description
4.1	(1)	Amended and Restated Certificate of Incorporation of the Registrant
4.2	(2)	Amended and Restated Bylaws of the Registrant
4.3	(3)	2018 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise, Stock Option Grant Notice. Restricted Stock Unit Notice and Restricted Stock Agreement thereunder.
4.4	(4)	2018 Employee Stock Purchase Plan
4.5	(5)	Specimen stock certificate evidencing shares of Common Stock
5.1	(6)	Opinion of Cooley LLP
23.1	(6)	Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm
23.2	(6)	Consent of Cooley LLP (included in Exhibit 5.1)
24.1	(6)	Power of Attorney (included on the signature page of this Form S-8)
107	(6)	Filing Fee Table

(1)Previously filed as Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 12, 2018, and incorporated by reference herein.

(2)Previously filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 12, 2018, and incorporated by reference herein.

(3)Previously filed as Exhibit 10.2 to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 29, 2018, and incorporated by reference herein.

(4)Previously filed as Exhibit 10.3 to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 29, 2018, and incorporated by reference herein.

(5)Previously filed as Exhibit 4.1 to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-222531), filed with the Commission on January 29, 2018, and incorporated by reference herein.

(6)Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S‑8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on January 29, 2024.

CARDLYTICS, INC.

By:

/s/ Karim Temsamani

Karim Temsamani

Chief Executive Officer

POWER OF ATTORNEY

Know All Persons By These Presents, that each person whose signature appears below constitutes and appoints Karim Temsamani, Nick Lynton and Alexis DeSieno, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

Signature

Title

Date

/s/ Karim Temsamani

Chief Executive Officer and Director

January 29, 2024

Karim Temsamani

(Principal Executive Officer)

/s/ Alexis DeSieno

Chief Financial Officer

January 29, 2024

Alexis DeSieno

(Principal Financial and Accounting Officer)

/s/ John Klinck

Chairperson

January 29, 2024

John Klinck

/s/ Jon Francis

Director

January 29, 2024

Jon Francis

/s/ Andre Fernandez

Director

January 29, 2024

Andre Fernandez

/s/ Scott Hill

Director

January 29, 2024

Scott Hill

/s/ Jessica Jensen

Director

January 29, 2024

Jessica Jensen

/s/ Aimée Lapic

Director

January 29, 2024

Aimée Lapic

/s/ Alex Mishurov

Director

January 29, 2024

Alex Mishurov

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed on / Effective on:	1/29/24
	1/1/24	3, 4
	9/30/23	10-Q
	6/30/23	10-Q
	4/10/23	ARS, DEF 14A, DEFA14A
	3/31/23	10-Q
	3/1/23	10-K, 8-K, POS AM, POSASR
	1/23/23	3, 4, 8-K, S-8
	12/31/22	10-K, ARS
	3/1/22	10-K, 8-K, S-8
	3/1/21	10-K, 424B5, 8-K, S-3ASR, S-8
	3/3/20	10-K, 8-K, S-8
	12/31/19	10-K
	5/21/19	S-8
	2/9/18	424B4, CT ORDER, EFFECT, S-8
	2/6/18	8-A12B, CORRESP
	1/29/18	S-1/A
	1/12/18	DRS, DRS/A, S-1
		List all Filings

19 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/02/24  Cardlytics, Inc.                  8-K:5,7,9  12/29/23   12:266K
12/19/23  Cardlytics, Inc.                  8-K:8      12/19/23   11:236K
11/08/23  Cardlytics, Inc.                  10-Q        9/30/23   69:7.9M
10/30/23  Cardlytics, Inc.                  8-K:5      10/24/23   11:236K
 9/19/23  Cardlytics, Inc.                  8-K:1,5,7,9 9/19/23   13:419K
 9/06/23  Cardlytics, Inc.                  8-K:5,7,9   9/05/23   12:258K
 8/01/23  Cardlytics, Inc.                  10-Q        6/30/23   72:7.7M
 7/18/23  Cardlytics, Inc.                  8-K:5,7,8   7/13/23   12:273K
 7/10/23  Cardlytics, Inc.                  8-K:5       7/06/23   11:241K
 7/05/23  Cardlytics, Inc.                  8-K:8       6/29/23   11:242K
 5/24/23  Cardlytics, Inc.                  8-K:5       5/23/23   10:264K
 5/04/23  Cardlytics, Inc.                  10-Q        3/31/23   73:7.7M
 5/01/23  Cardlytics, Inc.                  8-K:8       4/28/23   10:254K
 4/10/23  Cardlytics, Inc.                  DEF 14A               12:5.9M
 3/22/23  Cardlytics, Inc.                  8-K:5       3/17/23   10:235K
 3/14/23  Cardlytics, Inc.                  8-K:2       3/13/23   10:248K
 1/23/23  Cardlytics, Inc.                  8-K:5,7,9   1/23/23   11:284K
 1/29/18  Cardlytics, Inc.                  S-1/A                 12:5.7M                                   Donnelley … Solutions/FA
 1/12/18  Cardlytics, Inc.                  S-1                   20:8.8M                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001666071-24-000024 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Cardlytics, Inc. – ‘S-8’ on 1/29/24

On: Monday, 1/29/24, at 7:34am ET · Effective: 1/29/24 · Accession #: 1666071-24-24 · File #: 333-276737

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33Filing Table of Contents

‘S-8’ — Registration Statement – Securities for an Employee Benefit PlanDocument Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

19 Previous Filings that this Filing References

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

‘S-8’ — Registration Statement – Securities for an Employee Benefit Plan

Document Table of Contents